Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 2.39M | $ 44.47M | $ 46.86M |
3/31/2025 | $ 2.49M | $ 50.53M | $ 53.02M |
12/31/2024 | $ 16.27M | $ 55.08M | $ 71.35M |
9/30/2024 | $ 15.9M | $ 58.53M | $ 74.43M |
6/30/2024 | $ 15.54M | $ 60.41M | $ 75.95M |
3/31/2024 | $ 15.23M | $ 74.11M | $ 89.34M |
12/31/2023 | $ 15.08M | $ 72.96M | $ 88.04M |
9/30/2023 | $ 14.81M | $ 91.99M | $ 106.8M |
6/30/2023 | $ 14.7M | $ 93.08M | $ 107.78M |
3/31/2023 | $ 49.19M | $ -29.91M | $ 19.28M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for SCYNEXIS INC is calculated as follows: Debt [ $ 16.65M ] + Equity [ $ 9.56M ]
(=) Inv. Capital [ $ 26.21M ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.14B |
average | $ 762.5M |
median | $ 304.41M |
std | $ 1B |